4D Molecular Therapeutics, Inc.
(FDMT - NASDAQ)
9,45 USD
📋 Profilo Aziendale

4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors.

|